Merlin Inc MRLN 深 沪
已收盘 11-13 16:00:00 美东时间
1.13
+0.166
+17.17%
华盛通- 最 高1.38
- 今 开1.24
- 成交量 4247.44万股
- 最 低 1.09
- 昨 收 0.9644
- 总市值 1.14亿
- 52周最高 23.54
- 市盈率 静 6.35
- 换手率 42.03%
- 52周最低 0.741
- 委 比 -74.43%
- 总股本 1.01亿
- 历史最高 31.95
- 量 比 10.57
- 振 幅 30.07%
- 历史最低 0.741
- 每 手 1
- 风险率 3.51%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Roth Capital Maintains Buy on Merlin, Lowers Price Target to $4
Roth Capital analyst Suji Desilva maintains Merlin (NASDAQ:MRLN) with a Buy and lowers the price target from $10 to $4.
11-13 23:19
Merlin (MRLN) Stock Jumps Over 54% After Hours: What's Going On?
Merlin Inc. (NASDAQ:MRLN) shares surged 54.50% to $1.49 after the bell on Thursday, following the announcement of third-quarter results where earnings per share topped analyst estimates by 227.6%. The results covered the quarter ended Sept. 30. The stock had closed at $0.96 on Nov. 12, down 4.51%. R...
11-13 13:23
美股大行评级 | 潜在涨幅91.5%！巴克莱上调Vertical Aerospace评级至"标配"，目标价下调至1美元
今日重点评级关注：巴克莱：上调Vertical Aerospace评级至"标配"，目标价从2美元降至1美元；巴克莱：维持Bitdeer Technologies"超配"评级，目标价从15美元升至17美元
10-12 14:52
TD Cowen Maintains Buy on Merlin, Lowers Price Target to $4
TD Cowen analyst Gautam Khanna maintains Merlin (NASDAQ:MRLN) with a Buy and lowers the price target from $8 to $4.
10-09 23:37
美股大行评级 | Meta获4家机构看好！目标价最高升至950美元；好市多绩后齐遭机构降低目标价
今日重点评级关注：古根海姆：维持Damora Therapeutics"买入"评级，目标价从40美元升至60美元；HC Wainwright & Co.：维持Rezolute"买入"评级，目标价从5美元升至10美元
09-28 12:37
美股大行评级 | 奈飞遭看淡至57美元！现价仍有两成下行空间；Xenon制药遭多家机构降目标价，最低看至46美元
今日重点评级关注：康托·菲茨杰拉德：维持Abeona Therapeutics"超配"评级，目标价从28美元升至30美元；HC Wainwright & Co.：维持Oculis Holding"买入"评级，目标价从26美元升至39美元
09-21 16:25
Maxim Group Initiates Coverage On Merlin with Buy Rating, Announces Price Target of $7
Maxim Group analyst Matthew Galinko initiates coverage on Merlin (NASDAQ:MRLN) with a Buy rating and announces Price Target of $7.
09-18 23:51
美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价
今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元
08-17 13:37
Cantor Fitzgerald Maintains Overweight on Merlin, Lowers Price Target to $9
Cantor Fitzgerald analyst Andres Sheppard maintains Merlin (NASDAQ:MRLN) with a Overweight and lowers the price target from $11 to $9.
08-14 18:36
Merlin Achieves Next Stage in Certification of Its Autonomous Flight Technology
<p>Merlin Inc. achieved Stage of Involvement 3 (SOI 3) with the Civil Aviation Authority of New Zealand (CAANZ) for its Flight Control Computer (FCC) and Automated Communication System (ACS) under a certification program. This milestone confirms Merlin's software has been tested and verified, building on prior SOI 1 and SOI 2 achievements. Merlin also resolved an issue paper on AI/ML-based natural language processing, aligning with CAANZ on certi...
08-06 12:00
